All Relations between striatum and Alzheimer Disease

Publication Sentence Publish Date Extraction Date Species
D S Wolf, M Gearing, D A Snowdon, H Mori, W R Markesbery, S S Mirr. Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer disease and associated disorders. vol 13. issue 4. 2000-01-18. PMID:10609672. although diffuse plaques in the neocortex may represent an early stage in the evolution of neuritic plaques, plaques in the striatum and cerebellum retain their predominantly diffuse nature in alzheimer disease (ad), regardless of disease duration. 2000-01-18 2023-08-12 human
M A Piggott, E F Marshall, N Thomas, S Lloyd, J A Court, E Jaros, D Burn, M Johnson, R H Perry, I G McKeith, C Ballard, E K Perr. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain : a journal of neurology. vol 122 ( Pt 8). 1999-09-07. PMID:10430831. a slight, significant decrease in d3 binding in the caudal striatum of parkinson's disease (13%) patients and an increase in alzheimer's disease (20%) in the dorsal striatum at the level of the nucleus accumbens were found. 1999-09-07 2023-08-12 Not clear
F Boissière, B Faucheux, C Duyckaerts, J J Hauw, Y Agid, E C Hirsc. Striatal expression of glutamic acid decarboxylase gene in Alzheimer's disease. Journal of neurochemistry. vol 71. issue 2. 1998-08-19. PMID:9681468. to examine potential alteration of gabaergic striatal neurons in alzheimer's disease, we used quantitative in situ hybridization to analyze the messenger rna coding for mr 67,000 glutamic acid decarboxylase (gad67 mrna) in the striatum of five patients with alzheimer's disease (ad) and nine matched control subjects. 1998-08-19 2023-08-12 human
M Gearing, A I Levey, S S Mirr. Diffuse plaques in the striatum in Alzheimer disease (AD): relationship to the striatal mosaic and selected neuropeptide markers. Journal of neuropathology and experimental neurology. vol 56. issue 12. 1998-01-23. PMID:9413285. diffuse plaques in the striatum in alzheimer disease (ad): relationship to the striatal mosaic and selected neuropeptide markers. 1998-01-23 2023-08-12 Not clear
M Gearing, A I Levey, S S Mirr. Diffuse plaques in the striatum in Alzheimer disease (AD): relationship to the striatal mosaic and selected neuropeptide markers. Journal of neuropathology and experimental neurology. vol 56. issue 12. 1998-01-23. PMID:9413285. although neuritic and diffuse plaques generally coexist in alzheimer disease (ad) neocortex, the predominance of diffuse plaques in the striatum prompted us to explore the potential influence of striatal features such as the striatal mosaic on beta-amyloid (a beta) deposition. 1998-01-23 2023-08-12 Not clear
K Meguro, S Yamaguchi, M Itoh, T Fujiwara, A Yamador. Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: a double-tracer PET study. Neurology. vol 49. issue 4. 1997-11-14. PMID:9339671. we previously found that the rate of [l8f]6-fluoro-l-dopa (fdopa) uptake into the striatum (the ki value) in alzheimer's disease (ad) correlated with cognitive function. 1997-11-14 2023-08-12 Not clear
M J Brilliant, R J Elble, M Ghobrial, R G Strubl. The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer's disease. Neuropathology and applied neurobiology. vol 23. issue 4. 1997-11-06. PMID:9292871. the distribution of amyloid beta protein deposition in the corpus striatum of patients with alzheimer's disease. 1997-11-06 2023-08-12 Not clear
M J Brilliant, R J Elble, M Ghobrial, R G Strubl. The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer's disease. Neuropathology and applied neurobiology. vol 23. issue 4. 1997-11-06. PMID:9292871. the distribution of amyloid beta peptide (a beta) was quantified in the corpus striatum and pallidum of 10 patients with alzheimer's disease (ad) and three patients with both alzheimer's disease and parkinson's disease (ad-pd). 1997-11-06 2023-08-12 Not clear
R Rodríguez-Puertas, J Pascual, T Vilaró, A Pazo. Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease. Synapse (New York, N.Y.). vol 26. issue 4. 1997-09-09. PMID:9215593. we studied the autoradiographic densities of all pharmacologically characterised muscarinic receptors (mr) in frontal, temporal, and visual cortex, hippocampal formation, and striatum in autopsied brains from 19 histopathologically verified patients of alzheimer's disease (ad) and in matched controls. 1997-09-09 2023-08-12 Not clear
F Boissiere, B Faucheux, M Ruberg, Y Agid, E C Hirsc. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Experimental neurology. vol 145. issue 1. 1997-06-27. PMID:9184126. decreased trka gene expression in cholinergic neurons of the striatum and basal forebrain of patients with alzheimer's disease. 1997-06-27 2023-08-12 human
Y Shao, M Gearing, S S Mirr. Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study. Journal of neuropathology and experimental neurology. vol 56. issue 4. 1997-05-01. PMID:9100668. while apolipoprotein e (apoe) and beta-amyloid (a beta) co-localize in senile plaques in cortex and cerebellum in alzheimer disease (ad), the a beta-positive, predominantly diffuse plaques in the striatum do not exhibit apoe immunoreactivity regardless of disease duration. 1997-05-01 2023-08-12 Not clear
F Boissière, B Faucheux, Y Agid, E C Hirsc. Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease: an in situ hybridization study. Neuroscience letters. vol 221. issue 2-3. 1997-04-18. PMID:9121684. expression of catalytic trkb gene in the striatum and the basal forebrain of patients with alzheimer's disease: an in situ hybridization study. 1997-04-18 2023-08-12 human
F Boissière, B Faucheux, Y Agid, E C Hirsc. Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease: an in situ hybridization study. Neuroscience letters. vol 221. issue 2-3. 1997-04-18. PMID:9121684. the expression of catalytic trkb gene, encoding for the high affinity brain-derived neurotrophic factor (bdnf) and neurotrophin-4/5 (nt-4/5) receptor, was studied post mortem in the striatum and the nucleus basalis of meynert of patients with alzheimer's disease (ad) and control subjects, using in situ hybridization coupled with choline acetyltransferase immunohistochemistry. 1997-04-18 2023-08-12 human
P Förander, S Söderström, C Humpel, I Strömber. Chronic infusion of nerve growth factor into rat striatum increases cholinergic markers and inhibits striatal neuronal discharge rate. The European journal of neuroscience. vol 8. issue 9. 1997-01-02. PMID:8921273. infusion of nerve growth factor (ngf) has been used in combination with transplants of chromaffin tissue to the striatum in the rat model of parkinson's disease as well as to patients suffering from alzheimer's disease. 1997-01-02 2023-08-12 human
S Love, G K Wilcock, S M Matthew. No correlation between nigral degeneration and striatal plaques in Alzheimer's disease. Acta neuropathologica. vol 91. issue 4. 1996-11-27. PMID:8928622. although alzheimer's disease may involve both the substantia nigra and the striatum, there is little information concerning the relationship between the resulting abnormalities in these reciprocally interconnected regions of the brain. 1996-11-27 2023-08-12 Not clear
S Love, G K Wilcock, S M Matthew. No correlation between nigral degeneration and striatal plaques in Alzheimer's disease. Acta neuropathologica. vol 91. issue 4. 1996-11-27. PMID:8928622. we have examined the correlation between plaque density in the striatum and counts of neurons and neurofibrillary tangles in the pars compacta of the substantia nigra, in 12 cases of "pure" alzheimer's disease (i.e. 1996-11-27 2023-08-12 Not clear
S Love, G K Wilcock, S M Matthew. No correlation between nigral degeneration and striatal plaques in Alzheimer's disease. Acta neuropathologica. vol 91. issue 4. 1996-11-27. PMID:8928622. diffuse plaques in the striatum and neurofibrillary tangles in the substantia nigra were consistent findings in all of the alzheimer brains. 1996-11-27 2023-08-12 Not clear
A M Cataldo, J L Barnett, D M Mann, R A Nixo. Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome. Journal of neuropathology and experimental neurology. vol 55. issue 6. 1996-07-18. PMID:8642396. colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in alzheimer's disease and down's syndrome. 1996-07-18 2023-08-12 cat
A M Cataldo, J L Barnett, D M Mann, R A Nixo. Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome. Journal of neuropathology and experimental neurology. vol 55. issue 6. 1996-07-18. PMID:8642396. the lysosomal hydrolases, cathepsin d (cat d) and beta-hexosaminidase a (hex), which are normally intracellular enzymes, colocalize with beta-amyloid in a subgroup of diffuse plaques in the cerebellum and striatum of individuals with alzheimer's disease or down's syndrome. 1996-07-18 2023-08-12 cat
S Akbarian, M A Smith, E G Jone. Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia. Brain research. vol 699. issue 2. 1996-06-12. PMID:8616634. editing for an ampa receptor subunit rna in prefrontal cortex and striatum in alzheimer's disease, huntington's disease and schizophrenia. 1996-06-12 2023-08-12 human